Yabao Pharma and Frontage Ink $50 Million Collaboration

Yabao Pharmaceuticals Group of Beijing has signed a $50 million strategic collaboration agreement with Frontage Laboratories of Pennsylvania. Over the next five years, the two companies plan to develop sustained release delivery for more than 20 products, then submit them for approval in the US and Europe.  More details.... Stock Symbol: (SHA: 600351)